NPS Symposium Charles Berry House Tuesday November 3 rd 2015 Dr Rob Hampton

Slides:

Advertisements

Similar presentations

Daybook Speaker: Debbie Cuthbert INPS Training Consultant.

Advertisements

Strategic, service provider and user responses to reducing fatal and non-fatal poisonings Rowan Williams, Development Manager, Drugaid.

Suicide Prevention – a partnership approach Mark Smith Head of Suicide Prevention and Mental Health.

Edinburgh Shadow Strategic Planning Group Wednesday 18 March 2015.

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.

National Drug Programme Delivery Unit Supporting the implementation and quality delivery of drug treatment services. Drug Treatment in Prisons Future Directions.

NAPO AGM 2013 ‘Privatisation’ What really works in probation and social work Dr. Theo Gavrielides, IARS Founder & Director 17 th October 2013, Cymru Llandudno.

By Leigh Westmore With John Littlehales NPS – Update March 2015.

Dr Richard Stevenson. Confusing terminology “Designer Drugs” “Bath Salts” “Legal Highs” “Psychoactive drugs, newly available in the UK, which are not.

PRISON PSYCHIATRY Dr Melanie Baker Consultant in Forensic Psychiatry

European Early Warning System Charlotte Davies. European Early Warning System Adopted in May 2005, the Council Decision 2005/387/JHA on the information.

FORENSIC CLINICAL PSYCHOLOGY

/1 Dr Shanaya Rathod, DM, MRCPsych Consultant Psychiatrist, Southern Health NHS Foundation Trust Mental health Clinical lead: Wessex AHSN.

King County Regional Mental Health Court Navigating the mental health and chemical dependency communities.

The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS CARDS 2004, Component 4 Early Warning System Tim Pfeiffer-Gerschel National Focal Point.

Novel Psychoactive Substances

West Midlands Cardiovascular Strategic Clinical Network and Clinical Senate Rob Wilson Interim Associate Director and CVD Network Manager.

TOTAL POLICING New Psychoactive Substances – Public protection and law enforcement Ian Goldsborough Metropolitan Police Drugs Directorate (SC&O3 Specialist.

HR at the Heart of Improvement Jan Sobieraj Managing Director for NHS and Social Care Workforce Department of Health 8 th November 2011.

Annual report 2010: the state of the drugs problem in Europe.

Clinical Experience of Novel Psychoactive Substances Dr Richard Stevenson.

A look into the Expert Panels Review By Leigh

Reaching out to drug users and communities “ ” WDP Preventing HIV Yasmin Batliwala.

A Brief Insight By Leigh Westmore. New Psychoactive Substances Legal Highs Designer Drugs (70’s) Synthetic drugs “mimic known drugs” Possible long term.

Synthetic cannabinoid agonists (SCRAs) Harry Shapiro DrugScope.

Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.

MRCPsych addiction psychiatry seminar series Policy, guidance, service structures and legal framework of addiction treatment Epidemiology of addictive.

Current Trends: NPS and Young People in Midlothian.

Addiction in the Glasgow Forensic Community Mental Health Team Dr Laurence Tuddenham Consultant Forensic Psychiatrist Glasgow FCMHT Dr Laurence Tuddenham.

Senior Drug Users: Scotland April Shaw & Austin Smith November 2009.

Jack Stanley, Dr Daniel Mogford, Dr Rebecca Lawrence and Prof

Version and Date Here. Introduction to RAPt What RAPt Does RAPt works to help people with drug and alcohol dependence, both in prison and in the community,

Hitting a moving target Managing NPS harms Dr Owen Bowden-Jones Addiction Psychiatrist Imperial College London.

Pilot workshops Alcohol Commissioning Learning Programme 21 & 22 September 2010, City University London.

REDIFINING RECOVERY SUPPORTING SMALL ORGANISATIONS.

WEST MIDLANDS REDUCING REOFFENDING STEERING GROUP Adrian McNulty, Operations Director SWM CRC and Chair of Steering Group. Chief Inspector Paul Betts,

Website: eumadness.eu Novel Psychoactive Substances (NPS) - teaching of undergraduate healthcare professionals and educating the educators Society for.

The Mutual Aid Toolkit Megan Jones and Tony Mercer Megan Jones Senior Programme Manager Alcohol & Drugs Team Recovery from Addiction Conference University.

Psychoactive Substances Act 2016 Angela Scrutton Drugs Legislation Drugs and Alcohol Unit | Home Office.

NPS – An Update By Leigh Westmore. Intro News – Recent Changes – Headlines – Psychoactive Substances Bill 2015 – Truth behind the stats – How prohibition.

NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.

Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,

New Psychoactive Substances: an overview of the evidence Isla Wallace, Social Researcher Drugs Research Team

NPS Intravenous Use in the UK: Current Situation and Experiences Catherine Crawford, UK Focal Point.

§ NPS research Katy MacLeod National Training and Development Officer A national resource of expertise on drug issues.

Alcohol and Drug Problem in Poland. Implications for policy Janusz Sierosławski Institute of Psychiatry i Neurology 3rd Meeting of the Expert Group on.

July 2016 NOVEL PSYCHOACTIVE SUBSTANCES (NPS). Gain awareness of  the rapidly changing nature of the recreational drug scene,  trends in substance abuse,

Recovery Operations.

PLUS PROJECT: SUBSTANCE

Evidence from WY-FI Addiction and multiple needs

Research & Evaluation Manager - User Voice

Public Health Forum Adult Substance Misuse.

Evolving need and practice FDAP 15th June 2016

Chris Wilkins SHORE & Whariki Research Centre College of Health

National Institute of Legal Medicine and Forensic Sciences Lisbon

Public Health Priorities

The Bird Killer What prisoners think about the use of spice in prison

2. Drug Misuse and Dependency

Community Drug and alcohol treatment and recovery services

Development and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay. Annelies Cannaert, Jolien Storme, Florian.

Investigations of deaths in custody – trends and themes

Mark Thorpe, RMN – Program Lead for the Centre of Perfect Care

A collaboration between the Drugs Wheel and The Loop

Second European Conference on Addictive Behaviours and Dependencies

New Psychoactive Substances in Portugal

Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.

German Drug and Addiction Policy

Prison Inspection in England and Wales

Offender Health: Why Should We Care?

Presentation transcript:

NPS Symposium Charles Berry House Tuesday November 3 rd 2015 Dr Rob Hampton

Welcome & Housekeeping Fire Refreshments & food Toilets Wifi (BTHUB3 – password bfe437be22) Phones Slides/handouts

Scope for today 1.What is going on with NPS in LLR? – Problems – Solutions 2.Can all LLR agencies agree collective approaches? 3.Can we agree 5 actions?

NPS Definition Home Office’s Expert Panel October 2014 “psychoactive drugs, newly available in the UK, which are not prohibited by the United Nations Drug Conventions but which may pose a public health threat comparable to that posed by substances listed in these conventions.”

NPS Symposium FEWS Forensic Early Warning System Psychoactive Substances Bill NPS Resource pack MoJ NPS Initiative Operation Nitrox Neptune PHE NPS toolkit for commissioners RAPT (Rehabilitation for Addicted Prisoners Trust) Report Number 4 4 th International Conference on Novel Psychoactive Substances

‘Party Drugs, Club Drugs’ ‘NPS’ ‘Legal highs ’ Synthetic Cannabinoid Receptor Agonist (SCRA) ‘Synthetics’

Synthetic Cannabinoid Receptor Agonist (SCRA) Inspector of Prisons Report – Assault 10% rise – Assault on staff 28% rise – Deaths in Custody29% rise – Self harm 33% rise 19 NPS deaths (PPO), fold ‘mark-up’ profit – Opiates 3 fold ‘Spice pigs, Mamba Muppets, Mambulance’

Violence – direct or indirect? Indirect? - YOI Research Birmingham – debts, gangs, ‘escape’ Direct? – Front line experience – Service users recall – Non ‘synthetics’ service users Strength, paranoia, persistence, seizures, safety.

FEWS – Forensic Early Warning System 2014 Festivals, Headshops, Internet, Prisons – Completely different patterns Mixtures & unpredictable content Prisons – Non-controlled 738/762 (96%) – 5F-AKB-48 and 5F-PB22 in 78% samples Scope for testing??

Scope for today 1.What is going on with Synthetics in LLR? – Problems – Solutions 2.Can all LLR agencies agree collective approaches? 3.Can we agree 5 actions?

NPS Symposium First Speaker Charles Berry House Tuesday November 3 rd 2015 Jude Duncan NPS Lead LiFT CJDT Service User insight & Treatment Worker resources

NPS Symposium Second Speaker Charles Berry House Tuesday November 3 rd 2015 Tracy Carr Public Health England

NPS Symposium Third Speaker Charles Berry House Tuesday November 3 rd 2015 Dr Paul Smith Consultant Clinical Scientist and Forensic Toxicologist, University Hospitals of Leicester

5 Possible Actions